Medical Oncologist
CION Cancer Clinics
Why chemotherapy and radiation doses must be reduced in Fanconi anaemia | CION Cancer Clinics
People with Fanconi anaemia need much lower doses of many chemotherapy drugs and of radiation, because their healthy cells cannot repair the DNA damage these treatments cause. Standard doses can be dangerous. That is why the diagnosis should be known before cancer treatment starts. This page explains which treatments are affected, how teams plan around it, and who it does not apply to. At CION Cancer Clinics, our oncologists explain what a gene result means for you and your family, and plan the checks that follow.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Why do people with Fanconi anaemia need lower doses?
- Which treatments need the most care, and why?
- How does the team plan treatment safely?
- The treatment terms, in plain language
- Standard treatment compared with treatment in Fanconi anaemia
- What this page cannot tell you
- Four things families tell us, and what is actually true
- Common questions about treatment sensitivity
The short answer
Why do people with Fanconi anaemia need lower doses?
Many chemotherapy drugs, and radiation, work by damaging DNA. In Fanconi anaemia, a rare inherited condition that weakens DNA repair and wears out the bone marrow, healthy cells cannot fix that damage. Standard doses can therefore cause severe and sometimes fatal harm. Doses are cut sharply, and some treatments are avoided altogether.
Which treatments are affected most
The biggest problems come from drugs that glue DNA strands together, which is exactly the damage the Fanconi repair team exists to fix. These include cyclophosphamide, busulfan and melphalan, and the platinum drugs cisplatin and carboplatin. Radiation causes a similar kind of harm to nearby healthy tissue.
Why the diagnosis must come first
Fanconi anaemia is sometimes found only after a young person reacts badly to routine treatment. If a child has unexplained low blood counts, or a young adult has a mouth or throat cancer without tobacco use, the question should be asked before treatment starts. A chromosome breakage test can answer it. In India, mouth cancer is common and usually linked to chewed tobacco, so a young patient without that history deserves this question. So does a child with leukaemia and thumb or arm differences.
This applies to people with two faulty copies. A carrier with one faulty copy usually tolerates standard doses.Treatment by treatment
Which treatments need the most care, and why?
Every tissue in the body carries the same repair fault. That is why the effects reach far beyond the cancer itself.
DNA-crosslinking chemotherapy
Alkylating drugs and platinum drugs hit the exact weakness in Fanconi anaemia. At normal doses they can wipe out the remaining marrow and cause severe mouth and gut soreness. Mitomycin, another drug used in some cancers, acts the same way.
What the team does
- Uses a small fraction of the usual dose
- Chooses a different drug where one exists
Radiation therapy
Healthy skin, mouth and gut lining near the treated area can react far more strongly than expected. Radiation is used with great caution, often at reduced doses, or replaced by surgery where possible. Reactions can include skin breakdown, mouth soreness and trouble swallowing, and they can take longer to settle.
Preparing for a transplant
Before a bone marrow transplant, drugs are given to make room for the new marrow. In Fanconi anaemia these are gentler versions, often built around fludarabine, with far less cyclophosphamide and little or no radiation.
Scans and X-rays
The radiation in a single scan is small, but it adds up over a life of check-ups. Ultrasound and MRI, which use no radiation, are preferred where they answer the question. Keeping a record of past scans helps the next doctor judge this.
Not sure whether this applies to you?
Ask an oncologistIn practice
How does the team plan treatment safely?
Confirm the diagnosis first
If Fanconi anaemia is suspected, a breakage test is done before any DNA-damaging treatment. A short delay for testing is far safer than starting and reacting to harm.
Favour surgery for solid cancers
For a mouth or throat cancer, surgery that removes the tumour completely is usually the main treatment. It relies least on the body's ability to repair DNA.
Reduce and adapt the rest
Where chemotherapy or radiation is still needed, doses are reduced and drugs are swapped. Plans are shared with specialists who treat Fanconi anaemia regularly.
Watch closely and support early
Blood counts are checked more often, and support such as blood transfusions and antibiotics is ready before it is needed.
Words you will hear
The treatment terms, in plain language
- Alkylating drug
- A chemotherapy drug that sticks DNA strands together so cancer cells cannot divide.
- Platinum drug
- A chemotherapy drug built around platinum, such as cisplatin, that also sticks DNA strands together.
- Conditioning
- The treatment given before a transplant to clear space for the new marrow.
- Reduced-intensity
- A gentler version of that preparation, with lower doses.
- Radiosensitivity
- Healthy tissue reacting to radiation far more strongly than usual.
- Supportive care
- Transfusions, antibiotics and nutrition that carry a patient safely through treatment.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Side by side
Standard treatment compared with treatment in Fanconi anaemia
Usual approach
In Fanconi anaemia
Cisplatin with radiation is common for throat cancer
Surgery first, with any radiation reduced and cisplatin usually avoided
Full-dose transplant preparation
Reduced-intensity preparation
Standard blood count checks
More frequent checks, with support ready
CT scans used freely in follow-up
Ultrasound and MRI preferred where possible
Being straight with you
What this page cannot tell you
It cannot tell you the right dose for any one person. Doses are set case by case, from the person's blood counts, their past treatment and the cancer being treated. Studies guiding these choices are small, because the condition is rare, and specialists often compare notes across countries. It is reasonable to ask whether the team has treated Fanconi anaemia before, and whether they will consult a centre that has. That is a sensible question, not a sign of distrust.
It cannot promise that lower doses will work as well
Reducing a dose protects healthy tissue, but it can also mean less effect on the cancer. That trade-off is real. It is one reason finding cancers early, when surgery alone may be enough, matters so much in Fanconi anaemia.
Who this does not apply to
Carriers, who have one faulty copy, are not affected in this way. Someone with a single faulty BRCA2 or PALB2 copy may even be offered platinum drugs, because their tumour is sensitive while their healthy cells still repair normally. Two faulty copies of BRCA2 or PALB2 is different again, and behaves like Fanconi anaemia. If you are unsure which group you are in, ask before treatment starts.
Somatic, or tumour-only, gene testing to choose a targeted drug is a different question, covered under targeted therapy.Commonly believed
Four things families tell us, and what is actually true
"A lower dose means the doctors are giving up."
It means the doctors are protecting healthy tissue that cannot repair itself. A standard dose could do more harm than the cancer.
"Radiation is safer than chemotherapy for us."
Both damage DNA in the same broad way. In Fanconi anaemia, radiation needs as much caution as chemotherapy.
"One CT scan cannot matter."
One scan adds little. The concern is the total over a lifetime of check-ups, so the team asks whether each scan is needed and whether a radiation-free option would do.
"Carriers need reduced doses too."
Carriers have one working copy, and their healthy cells repair DNA normally. Standard treatment is usually safe for them.
Questions we are asked
Common questions about treatment sensitivity
How much lower are the doses?
It depends on the drug and the person. For some drugs the dose is a small fraction of the usual one, and others are avoided entirely. Your haematologist or oncologist will explain the plan for each drug, and it is fair to ask how they arrived at it.
What happens if standard chemotherapy was already given?
Tell the treating team at once that Fanconi anaemia has been diagnosed or suspected. They will watch blood counts closely and give support such as transfusions. Future treatment will be adjusted.
Is surgery safe in Fanconi anaemia?
Surgery does not rely on DNA repair in the same way, so it is generally the safest main treatment for solid cancers. Low platelet counts may need correcting before an operation, and wound healing is watched closely.
Are targeted drugs or immunotherapy safer?
Some are used, but experience in Fanconi anaemia is limited, and studies so far are small. The team weighs each drug case by case. None should be assumed safe without specialist advice.
Should my child avoid all X-rays?
No. An X-ray or scan that answers an important question should be done. The aim is to avoid scans that are not needed, and to choose ultrasound or MRI when they would give the same answer.
Does this apply to dental X-rays too?
Dental X-rays carry a very small dose, and good dental care matters a great deal in Fanconi anaemia. Tell the dentist about the condition, so X-rays are taken only when they will change what is done.
How do I make sure every hospital knows?
Carry a letter from the haematologist that names the condition and the drugs to avoid. Show it at every hospital visit, including emergencies. Keep a photo of it on your phone.
Who should plan treatment if cancer is found?
A team that includes a haematologist familiar with Fanconi anaemia, alongside the cancer specialists. Call the CION helpline if you need help finding the right team or a second opinion on a treatment plan.
Your Specialists
Meet CION's oncologists. Bring your family history or genetic report to them.
Our medical oncologists see people with a strong family history of cancer, arrange genetic counselling and testing where it fits, and plan the checks that follow.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Hematologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- GeneReviews (NCBI) — Fanconi Anemia
- MedlinePlus Genetics — Fanconi anemia
- National Cancer Institute — Chemotherapy to Treat Cancer
- National Cancer Institute — Radiation Therapy to Treat Cancer
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Fanconi anaemia and head and neck cancer in young adultsThe cancer where treatment choices matter mostThe Fanconi anaemia genes: what they doThe repair fault behind the sensitivityA Fanconi anaemia gene result: what happens nextThe first steps after a positive resultPharmacogenomics: why your genes change your doseOther gene results that change drug doses
Talk to us
Facing cancer treatment with Fanconi anaemia in the family?
Tell us the diagnosis and the treatment being planned. We will help you reach a haematologist and cancer team who can plan it safely. One helpline serves every CION centre.